These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
536 related items for PubMed ID: 27694900
1. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance. Ramadoss S, Sen S, Ramachandran I, Roy S, Chaudhuri G, Farias-Eisner R. Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900 [Abstract] [Full Text] [Related]
2. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53. Ramadoss S, Guo G, Wang CY. Oncogene; 2017 Jan 05; 36(1):47-59. PubMed ID: 27270439 [Abstract] [Full Text] [Related]
3. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation. Sørensen BH, Nielsen D, Thorsteinsdottir UA, Hoffmann EK, Lambert IH. Am J Physiol Cell Physiol; 2016 Jun 01; 310(11):C857-73. PubMed ID: 26984736 [Abstract] [Full Text] [Related]
4. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents. Mujoo K, Watanabe M, Nakamura J, Khokhar AR, Siddik ZH. J Cancer Res Clin Oncol; 2003 Dec 01; 129(12):709-18. PubMed ID: 14513366 [Abstract] [Full Text] [Related]
5. Chloroquine reverses chemoresistance via upregulation of p21WAF1/CIP1 and autophagy inhibition in ovarian cancer. Hwang JR, Kim WY, Cho YJ, Ryu JY, Choi JJ, Jeong SY, Kim MS, Kim JH, Paik ES, Lee YY, Han HD, Lee JW. Cell Death Dis; 2020 Dec 04; 11(12):1034. PubMed ID: 33277461 [Abstract] [Full Text] [Related]
6. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Choi EJ, Seo EJ, Kim DK, Lee SI, Kwon YW, Jang IH, Kim KH, Suh DS, Kim JH. Oncotarget; 2016 Jan 19; 7(3):3506-19. PubMed ID: 26654944 [Abstract] [Full Text] [Related]
7. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372. An J, Xu J, Li J, Jia S, Li X, Lu Y, Yang Y, Lin Z, Xin X, Wu M, Zheng Q, Pu H, Gui X, Li T, Lu D. Oncotarget; 2017 Jul 25; 8(30):49093-49109. PubMed ID: 28467776 [Abstract] [Full Text] [Related]
8. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. Wang H, Fang L, Jiang J, Kuang Y, Wang B, Shang X, Han P, Li Y, Liu M, Zhang Z, Li P. Cell Death Dis; 2018 Oct 30; 9(11):1103. PubMed ID: 30375398 [Abstract] [Full Text] [Related]
9. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway. Yang X, Zhang Q, Yang X, Zhao M, Yang T, Yao A, Tian X. Biochem Biophys Res Commun; 2019 Apr 16; 511(4):719-724. PubMed ID: 30827507 [Abstract] [Full Text] [Related]
10. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells. Wilson S, Fan L, Sahgal N, Qi J, Filipp FV. Oncotarget; 2017 May 02; 8(18):30328-30343. PubMed ID: 28416760 [Abstract] [Full Text] [Related]
11. GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells. Sakaki H, Okada M, Kuramoto K, Takeda H, Watarai H, Suzuki S, Seino S, Seino M, Ohta T, Nagase S, Kurachi H, Kitanaka C. Anticancer Res; 2015 Dec 02; 35(12):6607-14. PubMed ID: 26637876 [Abstract] [Full Text] [Related]
12. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F. Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971 [Abstract] [Full Text] [Related]
13. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling. Song Y, Li L, Xi Y. Tissue Cell; 2023 Dec 01; 85():102253. PubMed ID: 37890327 [Abstract] [Full Text] [Related]
14. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Ma L, Lai D, Liu T, Cheng W, Guo L. Acta Biochim Biophys Sin (Shanghai); 2010 Sep 01; 42(9):593-602. PubMed ID: 20705681 [Abstract] [Full Text] [Related]
15. Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B. Liu QQ, Li CM, Fu LN, Wang HL, Tan J, Wang YQ, Sun DF, Gao QY, Chen YX, Fang JY. Gut Microbes; 2020 Nov 09; 12(1):1788900. PubMed ID: 32684087 [Abstract] [Full Text] [Related]
16. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1. Chen JY, Li CF, Chu PY, Lai YS, Chen CH, Jiang SS, Hou MF, Hung WC. Oncotarget; 2016 May 10; 7(19):27689-710. PubMed ID: 27029061 [Abstract] [Full Text] [Related]
17. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression. Li M, Deng Y, Zhuo M, Zhou H, Kong X, Xia X, Su Z, Chen Q, Guo P, Mo P, Yu C, Li W. Theranostics; 2020 May 10; 10(19):8863-8879. PubMed ID: 32754284 [Abstract] [Full Text] [Related]
18. Acquisition of chemoresistance in a human ovarian carcinoma cell is linked to a defect in cell cycle control. Poulain L, Lincet H, Duigou F, Deslandes E, Sichel F, Gauduchon P, Staedel C. Int J Cancer; 1998 Nov 09; 78(4):454-63. PubMed ID: 9797134 [Abstract] [Full Text] [Related]
19. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L. Pedanou VE, Gobeil S, Tabariès S, Simone TM, Zhu LJ, Siegel PM, Green MR. Elife; 2016 Jul 29; 5():. PubMed ID: 27472901 [Abstract] [Full Text] [Related]
20. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice. Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, Sayed AAA, Choudhury S, Standing D, Subramaniam D, Padhye SB, Gunewardena S, Thomas SM, Neil MO, Tawfik O, Welch DR, Jensen RA, Maliski S, Weir S, Iwakuma T, Anant S, Dhar A. Gastroenterology; 2019 Dec 29; 157(6):1646-1659.e11. PubMed ID: 31442435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]